​

CollPlant Bio (CLGN) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

CLGN Stock Forecast

CollPlant Bio (CLGN) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $12.50, with a high of $14.00 and a low of $11.00. This represents a 644.05% increase from the last price of $1.68.

- $3 $6 $9 $12 $15 High: $14 Avg: $12.5 Low: $11 Last Closed Price: $1.68

CLGN Stock Rating

CollPlant Bio stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 5 Strong Sell Sell Hold Buy Strong Buy

CLGN Price Target Upside V Benchmarks

TypeNameUpside
StockCollPlant Bio644.05%
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$12.50
Last Closing Price$1.68$1.68$1.68
Upside/Downside--644.05%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-1---1
May, 25-1---1
Apr, 25-1---1
Mar, 2511---2
Feb, 2511---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 02, 2024Swayampakula RamakanthH.C. Wainwright$11.00$4.34153.46%554.76%
Aug 05, 2024Jason KolbertEF Hutton$14.00$4.65201.08%733.33%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 02, 2024H.C. WainwrightBuyBuyhold
Aug 21, 2024EF HuttonUnderperformUnderperformhold
Aug 05, 2024EF HuttonBuyinitialise

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.84$0.04$-1.52$-0.62-----
Avg Forecast$-1.07$0.32$-1.34$0.11$-1.08$-0.18$0.02$-0.28$-0.08
High Forecast$-0.95$0.35$-1.18$0.12$-0.95$-0.16$0.06$0.71$-0.07
Low Forecast$-1.18$0.29$-1.50$0.10$-1.21$-0.20$-0.02$-1.27$-0.09
Surprise %-21.50%-87.50%13.43%-663.64%-----

Revenue Forecast

$0 $5M $10M $15M $20M $25M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.14M$15.64M$299.00K$10.96M-----
Avg Forecast$6.88M$15.33M$324.00K$19.22M$451.00K$11.50M$18.00M$8.50M$15.00M
High Forecast$7.45M$16.60M$353.32K$24.73M$492.89K$12.57M$18.97M$9.29M$16.39M
Low Forecast$6.32M$14.07M$294.68K$13.72M$409.11K$10.43M$17.03M$7.71M$13.61M
Surprise %-10.86%2.02%-7.72%-42.99%-----

Net Income Forecast

$-20M $-14M $-8M $-2M $4M $10M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-5.81M$409.00K$-16.75M$-7.02M-----
Avg Forecast$-12.13M$3.64M$-15.26M$1.25M$-12.30M$-2.05M$-95.61K$-519.01K$-911.13K
High Forecast$-10.83M$4.04M$-13.47M$1.40M$-10.81M$-1.80M$637.79K$8.12M$-801.11K
Low Forecast$-13.43M$3.25M$-17.06M$1.10M$-13.79M$-2.30M$-182.23K$-14.50M$-1.02M
Surprise %-52.12%-88.78%9.77%-660.27%-----

CLGN Forecast FAQ

Is CollPlant Bio stock a buy?

CollPlant Bio stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that CollPlant Bio is a favorable investment for most analysts.

What is CollPlant Bio's price target?

CollPlant Bio's price target, set by 5 Wall Street analysts, averages $12.5 over the next 12 months. The price target range spans from $11 at the low end to $14 at the high end, suggesting a potential 644.05% change from the previous closing price of $1.68.

How does CollPlant Bio stock forecast compare to its benchmarks?

CollPlant Bio's stock forecast shows a 644.05% upside, outperforming the average forecast for the healthcare stocks sector (24.81%) and outperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for CollPlant Bio over the past three months?

  • June 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is CollPlant Bio’s EPS forecast?

CollPlant Bio's average annual EPS forecast for its fiscal year ending in December 2024 is $-1.08, marking a 74.19% increase from the reported $-0.62 in 2023. Estimates for the following years are $-0.18 in 2025, $0.02 in 2026, $-0.28 in 2027, and $-0.08 in 2028.

What is CollPlant Bio’s revenue forecast?

CollPlant Bio's average annual revenue forecast for its fiscal year ending in December 2024 is $451K, reflecting a -95.88% decrease from the reported $10.96M in 2023. The forecast for 2025 is $11.5M, followed by $18M for 2026, $8.5M for 2027, and $15M for 2028.

What is CollPlant Bio’s net income forecast?

CollPlant Bio's net income forecast for the fiscal year ending in December 2024 stands at $-12.3M, representing an 75.24% increase from the reported $-7.019M in 2023. Projections indicate $-2.05M in 2025, $-95.611K in 2026, $-519K in 2027, and $-911K in 2028.